annual cash & cash equivalents:
$154.57M+$75.75M(+96.10%)Summary
- As of today (May 20, 2025), LFST annual cash & cash equivalents is $154.57 million, with the most recent change of +$75.75 million (+96.10%) on December 31, 2024.
- During the last 3 years, LFST annual cash & cash equivalents has risen by +$6.54 million (+4.42%).
- LFST annual cash & cash equivalents is now at all-time high.
Performance
LFST Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$134.34M-$20.23M(-13.09%)Summary
- As of today (May 20, 2025), LFST quarterly cash & cash equivalents is $134.34 million, with the most recent change of -$20.23 million (-13.09%) on March 31, 2025.
- Over the past year, LFST quarterly cash & cash equivalents has increased by +$84.89 million (+171.65%).
- LFST quarterly cash & cash equivalents is now -51.36% below its all-time high of $276.19 million, reached on June 30, 2021.
Performance
LFST quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
LFST Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +96.1% | +171.7% |
| 3 y3 years | +4.4% | +17.9% |
| 5 y5 years | +4340.4% | - |
LFST Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +96.1% | -13.1% | +215.3% |
| 5 y | 5-year | at high | +4340.4% | -51.4% | +613.5% |
| alltime | all time | at high | +4340.4% | -51.4% | +613.5% |
LFST Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $134.34M(-13.1%) |
| Dec 2024 | $154.57M(+96.1%) | $154.57M(+50.6%) |
| Sep 2024 | - | $102.61M(+18.0%) |
| Jun 2024 | - | $86.97M(+75.9%) |
| Mar 2024 | - | $49.45M(-37.3%) |
| Dec 2023 | $78.82M(-27.4%) | $78.82M(+85.0%) |
| Sep 2023 | - | $42.60M(-46.5%) |
| Jun 2023 | - | $79.61M(+16.6%) |
| Mar 2023 | - | $68.29M(-37.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $108.62M(-26.6%) | $108.62M(+20.2%) |
| Sep 2022 | - | $90.34M(-6.6%) |
| Jun 2022 | - | $96.69M(-15.2%) |
| Mar 2022 | - | $113.99M(-23.0%) |
| Dec 2021 | $148.03M(+686.2%) | $148.03M(-30.2%) |
| Sep 2021 | - | $212.12M(-23.2%) |
| Jun 2021 | - | $276.19M(+599.3%) |
| Mar 2021 | - | $39.49M(+109.8%) |
| Dec 2020 | $18.83M(+440.9%) | $18.83M |
| Dec 2019 | $3.48M | - |
FAQ
- What is LifeStance Health annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for LifeStance Health?
- What is LifeStance Health annual cash & cash equivalents year-on-year change?
- What is LifeStance Health quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for LifeStance Health?
- What is LifeStance Health quarterly cash & cash equivalents year-on-year change?
What is LifeStance Health annual cash & cash equivalents?
The current annual cash & cash equivalents of LFST is $154.57M
What is the all time high annual cash & cash equivalents for LifeStance Health?
LifeStance Health all-time high annual cash & cash equivalents is $154.57M
What is LifeStance Health annual cash & cash equivalents year-on-year change?
Over the past year, LFST annual cash & cash equivalents has changed by +$75.75M (+96.10%)
What is LifeStance Health quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of LFST is $134.34M
What is the all time high quarterly cash & cash equivalents for LifeStance Health?
LifeStance Health all-time high quarterly cash & cash equivalents is $276.19M
What is LifeStance Health quarterly cash & cash equivalents year-on-year change?
Over the past year, LFST quarterly cash & cash equivalents has changed by +$84.89M (+171.65%)